Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ageless vs Ravia Health

Ageless
Graded #10

Higher grade

vs+25.599999999999994
Ravia Health
Graded #347

Lower grade

The verdict

Ageless takes it — 84.8/100 to 59.2/100.

Ageless grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the broadest compounded storefronts on the board — GLP-1, NAD+, sermorelin, TRT and more under one roof, in both injectable and oral routes, on low headline pricing (semaglutide $119/mo, tirzepatide $169/mo) — offset by a compounded-only catalog and an undisclosed state list.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgeless +45
90
45
Dose & formulationAgeless +37
90
53
Clinical oversightRavia Health +7
80
87
Labs & monitoringAgeless +13
78
65
FulfillmentAgeless +26
84
58
Contract termsAgeless +41
82
41
Ageless · left barRavia Health · right bar

The numbers

MetricAgelessRavia Health
WeighScore84.8/10059.2/100
GradeBC
Scorecard rank#10#347
Semaglutide$119/moNot disclosed
Tirzepatide$169/moNot disclosed
CoverageVaries by state1 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Ageless

Graded #10 · B

Strengths

  • Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
  • Low headline GLP-1 pricing — semaglutide $119/mo, tirzepatide $169/mo — no insurance, with Klarna/Affirm financing
  • Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures
  • Oral routes available (drops and troches), not injection-only

Where it loses points

  • Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
  • Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
  • No published state-availability list and no named legal entity or medical group
  • Thin public track record, and advertised prices are floors set after clinical review
Ravia Health

Graded #347 · C

Strengths

  • Integrative psychiatry model combines GLP-1 weight-loss with mental health and metabolic care under one board-certified NP provider
  • Founded by Dr. Raashida Portier (DNP, PMHNP-BC, FNP-BC); named clinician with dual board certifications in psychiatry and family medicine
  • Membership-supported ongoing care from $49/month provides medication management structure with consistent follow-up
  • Labs and metabolic workup available as part of integrative psychiatry model; lab testing noted in weight-loss program
  • Weight-loss page claims nationwide availability via Lyv Health partnership for eligible patients

Where it loses points

  • GLP-1 medication pricing fully gated — not disclosed until consultation; compounded vs. brand status unclear on public pages
  • Primarily a psychiatric practice — weight loss is a secondary service, not the core offering or brand identity
  • Core services explicitly Florida-only; nationwide weight-loss claim relies on Lyv Health partnership with unverified state coverage
  • No LegitScript certification or third-party accreditation found on public pages
  • Small single-provider practice with no published outcomes data or external reviews available

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard